Allianz Asset Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-541,480
Closed -$28M 2066
2022
Q3
$28M Buy
541,480
+454,955
+526% +$18.8M 0.06% 347
2022
Q2
$2.14M Buy
86,525
+12,240
+16% +$270K ﹤0.01% 1399
2022
Q1
$1.86M Buy
74,285
+10,497
+16% +$295K ﹤0.01% 1621
2021
Q4
$2.32M Buy
63,788
+43,959
+222% +$1.54M ﹤0.01% 1553
2021
Q3
$339K Sell
19,829
-12,228
-38% -$191K ﹤0.01% 2373
2021
Q2
$429K Buy
32,057
+134
+0.4% +$3.3K ﹤0.01% 2110
2021
Q1
$1.64M Sell
31,923
-4,872
-13% -$293K ﹤0.01% 1479
2020
Q4
$2.28M Sell
36,795
-71,356
-66% -$4.09M ﹤0.01% 1277
2020
Q3
$5.93M Buy
108,151
+14,910
+16% +$803K 0.01% 921
2020
Q2
$5.37M Sell
93,241
-14,477
-13% -$788K 0.01% 1176
2020
Q1
$4.33M Buy
107,718
+34,523
+47% +$1.47M 0.01% 1217
2019
Q4
$2.9M Buy
+73,195
New +$1.29M ﹤0.01% 1722

Other funds holding CCXI

Allianz Asset Management's CCXI Position: Q4 2022 in Review

Allianz Asset Management sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 541,480 shares — an estimated $28M sold.

Allianz Asset Management first reported a position in CCXI in Q4 2019 and held it in 12 quarters. The position peaked at $28M in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

  • Allianz Asset Management reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
  • Allianz Asset Management sold 541,480 ChemoCentryx, Inc. shares in Q4 2022, an estimated $28M.
  • Allianz Asset Management first reported a position in ChemoCentryx, Inc. in Q4 2019 and held it in 12 quarters.
  • Allianz Asset Management's ChemoCentryx, Inc. position peaked at $28M in Q3 2022.
  • 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Allianz Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.